“…McRae (1974) similarly mentions the value of brain scans in identifying meningiomas and arteriovenous malformations. Fischgold and Buisson-Ferey (1961) also found positive brain scans a useful indicator of brain tumours in epileptics.…”
Section: Introductionmentioning
confidence: 89%
“…As there were too few cases belonging to certain patterns these were eventually condensed into the groups as shown in (Rasmussen, 1968); and 9'5% of temporal lobe epileptics, 70% of whom have gliomas and about 80% developed their fits after the age of 25 years (Currie et al, 1971). Buisson-Ferey (1961) similarly noted that the type of seizure did not give an indication of the presence of tumour in adult epileptics.…”
Section: Introductionmentioning
confidence: 98%
“…As there were too few cases belonging to certain patterns these were eventually condensed into the groups as shown in (Rasmussen, 1968); and 9'5% of temporal lobe epileptics, 70% of whom have gliomas and about 80% developed their fits after the age of 25 years (Currie et al, 1971). Buisson-Ferey (1961) similarly noted that the type of seizure did not give an indication of the presence of tumour in adult epileptics. The present observations on the duration of fits in the presence of brain tumours is similar to that of Rasmussen and Blundell (1961) and of Gonzalez and Elvidge (1962) who found that astrocytomas can present as seizures for years without evidence of focal neurological signs or raised intracranial pressure.…”
“…McRae (1974) similarly mentions the value of brain scans in identifying meningiomas and arteriovenous malformations. Fischgold and Buisson-Ferey (1961) also found positive brain scans a useful indicator of brain tumours in epileptics.…”
Section: Introductionmentioning
confidence: 89%
“…As there were too few cases belonging to certain patterns these were eventually condensed into the groups as shown in (Rasmussen, 1968); and 9'5% of temporal lobe epileptics, 70% of whom have gliomas and about 80% developed their fits after the age of 25 years (Currie et al, 1971). Buisson-Ferey (1961) similarly noted that the type of seizure did not give an indication of the presence of tumour in adult epileptics.…”
Section: Introductionmentioning
confidence: 98%
“…As there were too few cases belonging to certain patterns these were eventually condensed into the groups as shown in (Rasmussen, 1968); and 9'5% of temporal lobe epileptics, 70% of whom have gliomas and about 80% developed their fits after the age of 25 years (Currie et al, 1971). Buisson-Ferey (1961) similarly noted that the type of seizure did not give an indication of the presence of tumour in adult epileptics. The present observations on the duration of fits in the presence of brain tumours is similar to that of Rasmussen and Blundell (1961) and of Gonzalez and Elvidge (1962) who found that astrocytomas can present as seizures for years without evidence of focal neurological signs or raised intracranial pressure.…”
“…Moreover they found that 8 of the 13 depressives (61%) showed a premorbid affective disturbance of depression. Currie et al (1971) found anxiety and depression to be the most frequent psychiatric abnormalities -101 -among 666 persons with TLE, occurring in 127 (19°/o) and 71 (11%) respectively. It is of interest to note that in 48 (7°/o), the symptoms of anxiety and depression antedated the first attacks of epilepsy.…”
“…У односу на тип епилепсије, психопатологија се посебно често јавља код болесника са комплексним фокусним нападима, односно са епилепсијом темпо-ралног режња (149,150). Према узроку епилепсије, психичке промене су далеко че-шће код симптоматске него идиопатске епилепсије.…”
Section: узроци психичких поремећаја код болесника са епилепсијомunclassified
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.